Mortality Risks and Life Expectancy Losses from COVID-19 Infections by Age for the United States

23 Pages Posted: 4 Feb 2021 Last revised: 24 Feb 2021

See all articles by Linus Wilson

Linus Wilson

University of Louisiana at Lafayette - College of Business Administration

Date Written: February 22, 2021

Abstract

We look at COVID-19 mortality and expected life expectancy risks by age prior to the development of pharmaceutical treatments for the SARS-CoV-2 virus. A COVID-19 infection more than doubled the annual mortality risks for Americans over sixty. Americans aged sixty or older stand to lose 153 to 222 days of life expectancy from contracting COVID-19 without the benefits of pharmaceutical treatments or vaccines.

Note: Funding: I received no funding for the study.

Declaration of Interests: I have no conflicts of interest with regard to "Mortality Risks and Life Expectancy Losses from COVID-19 Infections by Age for the United States."

Keywords: actuarial tables, mortality, death rates, CFR, COVID-19, IFR, SARS-CoV-2

JEL Classification: G22, I1, I18, J31, J65, K32

Suggested Citation

Wilson, Linus, Mortality Risks and Life Expectancy Losses from COVID-19 Infections by Age for the United States (February 22, 2021). Available at SSRN: https://ssrn.com/abstract=3776422 or http://dx.doi.org/10.2139/ssrn.3776422

Linus Wilson (Contact Author)

University of Louisiana at Lafayette - College of Business Administration ( email )

Department of Economics & Finance
214 Hebrard Blvd., Room 326
Lafayette, LA 70504-0200
United States
(337) 482-6209 (Phone)
(337) 482-6675 (Fax)

HOME PAGE: http://www.linuswilson.com

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
157
Abstract Views
1,056
rank
224,971
PlumX Metrics